-
1
Advancing diagnosis and treatment for human African trypanosomiasis in Nigeria: challenges and future directions
Published 2025-01-01Subjects: Get full text
Article -
2
Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d'Ivoire using an integrated approach.
Published 2023-07-01“…<h4>Background</h4>Human African trypanosomiasis is a parasitic disease caused by trypanosomes among which Trypanosoma brucei gambiense is responsible for a chronic form (gHAT) in West and Central Africa. …”
Get full text
Article -
3
Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad.
Published 2023-07-01“…Human African trypanosomiasis, caused by the gambiense subspecies of Trypanosoma brucei (gHAT), is a deadly parasitic disease transmitted by tsetse. …”
Get full text
Article -
4
Conducting active screening for human African trypanosomiasis with rapid diagnostic tests: The Guinean experience (2016-2021).
Published 2024-02-01“…Strategies to detect Human African Trypanosomiasis (HAT) cases rely on serological screening of populations exposed to trypanosomes. …”
Get full text
Article -
5
A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC.
Published 2023-04-01“…Gambiense human African trypanosomiasis (gHAT) is a deadly vector-borne, neglected tropical disease found in West and Central Africa targeted for elimination of transmission (EoT) by 2030. …”
Get full text
Article -
6
Systematic Review and Meta-Analysis on Knowledge Attitude and Practices on African Animal Trypanocide Resistance
Published 2023Subjects: Get full text
Article -
7
Identification des Villages à Risque (IVR) : pour un état des lieux de la Trypanosomiase Humaine Africaine au Niger
Published 2019-11-01Subjects: Get full text
Article -
8
Is the elimination of ‘sleeping sickness’ affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis Trypanosoma brucei gambiense in sub-Saharan Africa
Published 2019-03-01“…It is hoped that elimination of human African trypanosomiasis (HAT) Trypanosoma brucei gambiense (Tbg) would assist in this goal, but the financial costs are still unknown. …”
Get full text
Article -
9
-
10
Population genetics of Glossina palpalis gambiensis in the sleeping sickness focus of Boffa (Guinea) before and after eight years of vector control: no effect of control despite a...
Published 2024-02-01Subjects: “…Tsetse flies; Human African Trypanosomiasis; Population structure; Effective population size; Vector control; Neglected Tropical Diseases…”
Get full text
Article -
11
Epidemiology of Trypanosomiasis in Wildlife—Implications for Humans at the Wildlife Interface in Africa
Published 2023Subjects: Get full text
Article -
12
Dual suppression of Glossina pallidipes using entomopathogenic fungal-based biopesticides and sterile insect technique
Published 2024-12-01Subjects: Get full text
Article -
13
Systematic Review and Meta-Analysis on Human African Trypanocide Resistance
Published 2023Subjects: “…Human African trypanosomiasis…”
Get full text
Article -
14
In Vitro Mechanism of Action of Acanthospermum hispidum in Trypanosoma brucei
Published 2022-01-01“…African trypanosomiasis is a major neglected tropical disease with significant health and economic concerns in sub-Saharan Africa. …”
Get full text
Article -
15
A murine model of Trypanosoma brucei-induced myocarditis and cardiac dysfunction
Published 2025-02-01“…However, this aspect of African trypanosomiasis remains poorly understood, partially due to a lack of well-characterized and practical animal models. …”
Get full text
Article -
16
The current status of neglected tropical diseases in Japan: A scoping review.
Published 2024-01-01“…At least one laboratory offers diagnostic testing for each NTD except for dracunculiasis, human African trypanosomiasis, onchocerciasis, and yaws. No medicine is approved for treatment of Chagas disease and fascioliasis and only off-label use drugs are available for cysticercosis, opisthorchiasis, human African trypanosomiasis, onchocerciasis, schistosomiasis, and yaws. …”
Get full text
Article -
17
Prevalence of Trypanosoma congolense and Trypanosoma vivax in Lira District, Uganda
Published 2021“…Trypanosomes are the causative agents of animal African trypanosomiasis (AAT) and human African trypanosomiasis (HAT), the former affecting domestic animals prevalent in Sub-Saharan Africa. …”
Get full text
Article -
18
Prevalence of Trypanosoma congolense and Trypanosoma vivax in Lira District, Uganda
Published 2021“…Trypanosomes are the causative agents of animal African trypanosomiasis (AAT) and human African trypanosomiasis (HAT), the former affecting domestic animals prevalent in Sub-Saharan Africa. …”
Get full text
Article -
19
African animal trypanocide resistance: A systematic review and meta-analysis
Published 2023“…Background: African animal trypanocide resistance (AATr) continues to undermine global efforts to eliminate the transmission of African trypanosomiasis in endemic communities. The continued lack of new trypanocides has precipitated drug misuse and overuse, thus contributing to the development of the AATr phenotype. …”
Get full text
Article -
20
An Update on African Trypanocide Pharmaceutics and Resistance.
Published 2023“…African trypanosomiasis is associated with Trypanosoma evansi, T. vivax, T. congolense, and T. brucei pathogens in African animal trypanosomiasis (AAT) while T. b gambiense and T. b rhodesiense are responsible for chronic and acute human African trypanosomiasis (HAT), respectively. …”
Get full text
Article